
This study was designed to evaluate the impact of long-term zzso use on the subsequent risk of benign brain tumor zzso or zzso brain tumor zzso zzso 

We used data from the National Health Insurance System of zzso For the study zzso we identified zzso patients who had been prescribed zzso for at least 2 months between January 1, 2000 and December, 31, zzso For each of the zzso cases, we randomly selected one insured person from the zzso cohort with frequency matching sex, age, and year of index zzso The zzso cohort comprised zzso zzso The related hazard ratios zzso and zzso confidence intervals zzso of developing brain tumors were zzso 

The overall zzso zzso rate was zzso higher in the zzso cohort than the zzso cohort zzso vs zzso per 100,000 zzso with an adjusted zzso of zzso zzso zzso Similarly, the zzso zzso rate was zzso higher in the zzso cohort zzso vs zzso per 1000 zzso and the adjusted zzso of zzso zzso zzso was not statistically zzso When compared with the zzso zzso the adjusted zzso of zzso increased with zzso dosage zzso zzso zzso zzso for zzso zzso adjusted zzso zzso zzso for zzso zzso 

In this zzso study, we found a significant increase in the risk of benign brain tumor development in a cohort of long-term zzso zzso 

